Pornpen SrisawasdiPatcharee JearanaikoonNuanchawee WetprasitBusarawan SriwanthanaMartin H. KrollPorntip H. LolekhaMahidol UniversityKhon Kaen UniversityNational Institutes of Health, BethesdaVA Medical Center2018-08-202018-08-202006-10-01Clinica Chimica Acta. Vol.372, No.1-2 (2006), 103-111000989812-s2.0-33748151382https://repository.li.mahidol.ac.th/handle/20.500.14594/22971Background: Using non-esterified cholesterol standard, Brevibacterium and Streptomyces are found as suitable sources of cholesterol oxidase for kinetic cholesterol assay. For clinical use, we investigated the suitability of these enzymes for cholesterol determination in human serum. Methods: We compared the performance of reagents containing 2 enzymes for the kinetic determination of total serum cholesterol with the standardized endpoint method. Results: Reagent containing Streptomyces enzyme was more sensitive than that of Brevibacterium, with linearity up to 20.7 and 2.6 mmol/l, respectively. The analytical reaction for Streptomyces showed a shorter lag phase (148 s) and a steeper slope (absorbance vs. time) than that of Brevibacterium (246 s). The assay using Streptomyces reagent was precise and accurate and compared favorably with the endpoint method (y = 1.06x - 0.15, r = 0.996, bias = 0.21 mmol/l). Hemoglobin as high as 7.5 g/l did not interfere while turbidity greater than 2+ (absorbance > 0.778 at 670 nm) and bilirubin concentrations > 171.0 μmol/l did interfere (in a negative interference). Reagent was stable up to at least 8 weeks. Conclusions: The Streptomyces cholesterol oxidase, with 3,4-dichlorophenol, proved a suitable source for serum total cholesterol determination by the kinetic method. © 2006 Elsevier B.V. All rights reserved.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyMedicineArticleSCOPUS10.1016/j.cca.2006.03.030